大摩:升閲文(0772.HK)目標價至33港元 評級“大市同步”
大摩發表的研究報告指,預期閲文集團(0772.HK)去年下半年線上閲讀及知識產權方面的收入均會有復甦,對付費閲讀模式感樂觀,並估計新麗傳媒作為內容供應商市佔將有提升,將其目標價由22港元升至33港元,但估值合理,維持“大市同步”評級。
該行估計公司去年下半年收入將39億元人民幣(下同),按年增長41.1%,較上半年升30.9%,當中線上業務收入將按年跌7.6%至18億元,但與上半年比較則升8.3%,主要考慮廣告收入將有所增加。而在知識產權方面,該行估計收入將為20億元,較上半年升62.4%,主要因為下半年有較多劇集推出。估計公司按非通用會計準則計算,下半年純利將為5.51億元,料利潤亦有所改善。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.